Haematological manifestations in primary hyperparathyroidism.
Anaemia
haematological manifestations of systemic diseases
leucopenia
primary hyperparathyroidism
thrombocytopenia
Journal
The Indian journal of medical research
ISSN: 0971-5916
Titre abrégé: Indian J Med Res
Pays: India
ID NLM: 0374701
Informations de publication
Date de publication:
01 2022
01 2022
Historique:
entrez:
21
7
2022
pubmed:
22
7
2022
medline:
23
7
2022
Statut:
ppublish
Résumé
Primary hyperparathyroidism (PHPT) is a common endocrine disorder caused by the elevated secretion of the parathormone (PTH). The aim of this study was to evaluate the haematological manifestations of PHPT in patients with normal renal functions who were treated surgically for parathyroid adenomas. In this retrospective cross-sectional study, 134 patients with normal renal functions who underwent parathyroidectomies for PHPT were included. The haematological manifestations were evaluated in the total study cohort and in the two groups of different calcium (Ca) levels (Group 1 ≤11.2 mg/dl and Group 2 >11.2 mg/dl). The overall prevalence of anaemia, leucopenia and thrombocytopenia was 20.1, 6.7 and 6.0 per cent, respectively. Normocytic anaemia was present in 19 (14.2%) patients. There were no significant differences in the prevalence of anaemia, leucopenia and thrombocytopenia between the two groups. There were no correlations between the PTH levels and the leukocyte, haemoglobin or platelet values. Six to 12 months after the parathyroidectomy (PTX), 35.7 per cent of the patients with anaemia, 85.7 per cent of the patients with leucopenia and 100 per cent of the patients with thrombocytopenia had recovered. In the present study, anaemia was seen with a variable frequency in PHPT, but there was no relationship between anaemia and high PTH or Ca levels. The development of anaemia can be seen regardless of the PTH levels in PHPT patients with normal renal functions. High-resolution rates after PTX indicate a possible association between PHPT and thrombocytopenia or leucopenia, although their prevalence is low in PHPT.
Sections du résumé
Background & objectives
Primary hyperparathyroidism (PHPT) is a common endocrine disorder caused by the elevated secretion of the parathormone (PTH). The aim of this study was to evaluate the haematological manifestations of PHPT in patients with normal renal functions who were treated surgically for parathyroid adenomas.
Methods
In this retrospective cross-sectional study, 134 patients with normal renal functions who underwent parathyroidectomies for PHPT were included. The haematological manifestations were evaluated in the total study cohort and in the two groups of different calcium (Ca) levels (Group 1 ≤11.2 mg/dl and Group 2 >11.2 mg/dl).
Results
The overall prevalence of anaemia, leucopenia and thrombocytopenia was 20.1, 6.7 and 6.0 per cent, respectively. Normocytic anaemia was present in 19 (14.2%) patients. There were no significant differences in the prevalence of anaemia, leucopenia and thrombocytopenia between the two groups. There were no correlations between the PTH levels and the leukocyte, haemoglobin or platelet values. Six to 12 months after the parathyroidectomy (PTX), 35.7 per cent of the patients with anaemia, 85.7 per cent of the patients with leucopenia and 100 per cent of the patients with thrombocytopenia had recovered.
Interpretation & conclusions
In the present study, anaemia was seen with a variable frequency in PHPT, but there was no relationship between anaemia and high PTH or Ca levels. The development of anaemia can be seen regardless of the PTH levels in PHPT patients with normal renal functions. High-resolution rates after PTX indicate a possible association between PHPT and thrombocytopenia or leucopenia, although their prevalence is low in PHPT.
Identifiants
pubmed: 35859427
pii: IndianJMedRes_2022_155_1_43_350965
doi: 10.4103/ijmr.IJMR_1200_19
pmc: PMC9552388
doi:
Substances chimiques
Parathyroid Hormone
0
Calcium
SY7Q814VUP
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
43-48Références
Arch Intern Med. 1977 May;137(5):588-93
pubmed: 857757
Clin Cases Miner Bone Metab. 2017 Jan-Apr;14(1):97-100
pubmed: 28740534
Nephron. 1991;59(3):384-93
pubmed: 1758526
South Med J. 1977 Oct;70(10):1199-201
pubmed: 910174
Horm Metab Res. 1997 Aug;29(8):387-92
pubmed: 9288576
Clin Endocrinol (Oxf). 2009 Apr;70(4):527-32
pubmed: 18727711
Medicine (Baltimore). 1974 Mar;53(2):127-46
pubmed: 4361513
J Clin Invest. 1981 May;67(5):1263-9
pubmed: 7229028
Osteoporos Int. 2017 Jan;28(1):1-19
pubmed: 27613721
Updates Surg. 2017 Jun;69(2):217-223
pubmed: 28646423
Braz J Med Biol Res. 2002 Jan;35(1):25-9
pubmed: 11743611
N Engl J Med. 1993 Jan 21;328(3):171-5
pubmed: 8417383
J Clin Endocrinol Metab. 2012 May;97(5):1420-2
pubmed: 22419706
Indian J Endocrinol Metab. 2015 Sep-Oct;19(5):691-2
pubmed: 26425486
J Bone Miner Metab. 2018 Mar;36(2):238-245
pubmed: 28364324
Arch Intern Med. 1978 Nov;138(11):1650-2
pubmed: 718313
Biochem J. 1989 May 1;259(3):785-9
pubmed: 2543369
Nephron. 1996;72(4):683-7
pubmed: 8730443
Exp Clin Endocrinol Diabetes. 2004 Mar;112(3):127-30
pubmed: 15052531
Nephrologie. 1986;7(1):28-30
pubmed: 3960258
J Lab Clin Med. 1983 Oct;102(4):613-20
pubmed: 6311928
Endocrinology. 2005 Sep;146(9):4074-81
pubmed: 15947001